News
REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback